Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation

Stroke

Volumn 21, Issue 1, 1990, Pages 47-51

  Gustafsson, Claes ^a   Blombäck, Margareta ^c   Britton, Mona ^a   Hamsten, Anders ^d   Svensson, Jan ^b  

^a Departments of Medicine   (Sweden)

^b DANDERYD HOSPITAL   (Sweden)

^c Div Clin Chem Blood Coagul K   (Sweden)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Atrial fibrillation; Cerebrovascular disorders blood coagulation; Fibrinolysis

Indexed keywords

BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR; FIBRINOGEN; FIBRINOPEPTIDE A; PREKALLIKREIN;

ADULT; AGED; ARTICLE; FEMALE; HEART ATRIUM FIBRILLATION; HEMOSTASIS; HUMAN; MALE; PRIORITY JOURNAL; STROKE;

ACUTE-PHASE REACTION; AGED; AGED, 80 AND OVER; ATRIAL FIBRILLATION; BLOOD COAGULATION FACTORS; CEREBROVASCULAR DISORDERS; FEMALE; HUMAN; MALE; MIDDLE AGE; OSMOLAR CONCENTRATION; RISK FACTORS; SEX CHARACTERISTICS; SUPPORT, NON-U.S. GOV'T;

EID: 0025129155     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.21.1.47     Document Type: Article

References (34)

1. Landahl S, Svanborg A, Astrand K: Heart volume and the prevalence of certain common cardiovascular disorders at age 70 and 75. Eur Heart J 1984; 5: 326-331
2. Wolf PA, Dawber TR, Emerson T Jr, Kannel WB: Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The Framingham Study. Neurology 1978; 28: 973-977
3. Britton M, Gustafsson C: Non-rheumatic atrial fibrillation as a risk factor for stroke. Stroke 1985; 16: 182-188
4. Hart RG, Coull BH, Hart D: Early recurrent embolism associated with nonvatvular atrial fibrillation: A retrospective study. Stroke 1983; 14: 688-693
5. Mettinger KL: A study of hemostasis in ischemic cerebrovascular disease. V. A multivariate evaluation of risk indicators and predictors. Early results of a longitudinal study. Thromb Res 1982; 28: 521-532
6. Meade TW, Brozovic M, Chakrabarti RR, Haines AP, Imeson ID, Mellows S, Miller GJ, North WRS, Stirling Y, Thompson SG: Haemostatic functions and ischaemic heart disease: Principal results of the Northwich Park Heart Study. Lancet 1986; 1: 533-537
7. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen R, Larsson B, Welin L, Tibblin G: Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med 1984; 311: 501-505
8. Hamsten A, Blombäck H, Wiman B, Svensson J, Szamosi A, de Faire U, Mettinger L: Haemostatic function in myocardial infarction. Br Heart J 1986; 5: 58-66
9. Laurell CB: Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Anal Biochem 1966; 15: 45-52
10. Ludlam CA, Moore S, Bolton AE, Pepper DS, Cash JD: The release of a human platelet specific protein measured by a radioimmuno assay. Thromb Res 1975; 6: 543-548
11. Hardisty RM, MacPherson JC: A one-stage factor VIII (anti haemophilic globulin) assay and its use on venous and capillary plasma. Thromb Diathes Haemorrh 1962; 7: 215-229
12. Savidge GF, Blomback M,. Blomback B: Studies of factor VIII procoagulant activity in plasma and concentrates using a semiautomated thrombin generation assay. Thromb Res 1979; 16: 355-365
13. Denson KWE: The ratio of factor VIII-related antigen and factor VIII biological activity as an index of hypercoagulability and intravascular clotting. Thromb Res 1977; 10: 107-119
14. Abildgaard U, lie M, Odegard OR: Antithrombin (heparin cofactor) assay with “new” chromogenic substrates (S-2238 and Chromozym TH). Thromb Res 1977; 11: 549-553
15. Vermylen C, de Vreker RA, Verstraete M: A rapid enzymatic method for assay of fibrinogen fibrin polymerization time (FPT test). Clin Chim Acta 1963; 8: 418-424
16. Nilsen DWT, Jeremic M, Weisert OK: An attempt at predicting postoperative deep vein thrombosis by preoperative coagulation studies in patients undergoing total hip replacement. Thromb Haemost 1980; 43: 194-197
17. Bertina RM, Broekmans AW, van der Linden IK, Mertens KJ: Protein C deficiency in a Dutch family with thrombotic disease. Thromb Haemost 1982; 48: 1-5
18. Norén I, Ramström G, Wallén P: Fibrin plate method with reagents purified by affinity chromatography and its use for determination of fibrinolytic and other proteolytic activity in saliva, bile and plasma. Haemostasis 1975; 4: 110-124
19. Chmielewska J, Ränby M, Wiman B: Evidence for a rapid inhibitor to tissue plasminogen activator in plasma. Thromb Res 1983; 31: 427-436
20. Teger-Nilsson AC, Friberger P, Gyzander E: Determination of a new rapid plasmin inhibitor in human bloods by means of a plasmin specific tripeptide substrate. Scand J Clin Lab Invest 1977; 37: 403-409
21. Gallimore MJ, Friberger P: Simple chromogenic peptide substrate assays for determining prekallikrein, kallikrein inhibition and kal likre in “like” activity in human plasma. Thromb Res 1982; 25: 293-298
22. Fsssler H, Duckert F, Marbet GA: Assay with chromogenic substrates of in vivo activated proteases. Haemostasis 1978; 7: 158-163
23. Nossel HL, Younger LR, Wilner GD, Procupez T, Canfield RE, Butler VP Jr: Radioimmunoassay of human fibrinopep-tide A. Proc Natl Acad Sci USA 1971; 68: 2350-2353
24. Kockum C, Frebelius S: Rapid radioimmunoassay of human fibrinopeptide A-Removal of crossreacting fibrinogen with bentonite. Thromb Res 1980; 19: 589-598
25. Ehns MJ, Bunce IH, Bundesen PG, Rylatt DB, Webber AJ, Masci PP, Whitaker AN: Measurement of crosslinked fibrin degradation products-An immunoassay using monoclonal antibodies. Thromb Haemost 1983; 0: 591-594
26. Kannel WB, Wolf PA, CasteUi WP, D’Agostino RB: Fibrinogen and risk of cardiovascular disease. The Framingham Study. JAMA 1987; 258: 1183-1186
27. Myreng Y, Aursnes I, Hjermann I, Stormorken H, Sund T, Hellem A: von Willebrand factor and cardiovascular risk. Thromb Res 1986; 41: 867-871
28. Uchiyama S, Takeuchi M, Osawa M, Kobayashi I, Maruyama S, Aosaki M, Hirosawa K: Platelet function tests in thrombotic cerebrovascular disorders. Stroke 1983; 14: 511-516
29. Murano G: Plasma protein function in hemostasis, in Basic Concepts of Hemostasis and Thrombosis. Boca Raton, Fla, CRC Press Inc, 1981, pp 43-78
30. Shah AB, Beamer N, Coull BM: Enhanced in vivo platelet activation in subtypes of ischemic stroke. Stroke 1985; 16: 643-647
31. Taomoto K, Asada M, Kanazawa Y, Matsumoto S: Usefulness of the measurement of plasma; thromboglobulin (β-TG) in cerebrovascular disease. Stroke 1983; 14: 518-524
32. Marra R, De Stefano V, Pagano L, Giovanni G, Bizzi B: Evaluation of some coagulation parameters in cerebral ischemia. Acta Neurol Scand 1983; 67: 210-217
33. Mettinger KL: A study of hemostasis in ischemic cerebrovascular disease IV. A five year follow up of some blood coagulation parameters also including fibrinopeptide A, factor XII and prekallikrein. Thromb Res 1982; 27: 155-160
34. Mettinger KL, Egberg N: A study of hemostasis in ischemic cerebrovascular disease. III. Abnormalities in vascular plasminogen activators, an tiactivators and alpharantiplasmin. Thromb Res 1982; 26: 203-210